PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 31977

Proceedings of the 4th Conference on Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Division of Cancer Cause and Prevention, National Cancer Institute.

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Adjuvants, ImmunologicCongresses as TopicHumansImmunotherapyNational Institutes of Health (U.S.)NeoplasmsUnited StatesConference Proceedings

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

1978. Proceedings of the 4th Conference on Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Division of Cancer Cause and Prevention, National Cancer Institute.. https://pubmed.ncbi.nlm.nih.gov/31977/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1979

[Effectiveness of a new "paramunity" inducer (PIND-AVI) for human beings and animals].

Attenuated and by treatment with gamma rays inactivated avian Pox viruses (PIND-AVI) stimulate in man and animals selectively the T-lymphocytes. In this way PIND-AVI helps to repair a reduced reactivity of lymphocytes damaged by cytostatic chemotherapy: The lymphocyte stimulation by phytohemagglutinin could be normalized. In immunodeficient patients PIND-AVI showed very good effects in the treatment of herpes Virus infections.

Adjuvants, Immunologic↗
PubMed1979

[Immunostimulating and adjuvant activities of a low molecular weight lipopeptide].

From crude extracts of a Streptomyces strain exhibiting immunopotentiating effects, a tetrapeptide was isolated and its structure established as L Ala leads to D isoGlu leads to L, L Dap comes from Gly. This peptide was devoid of biological activity but its chemical coupling with lauric acid gave a substance endowed with adjuvant and immunostimulating properties. This substance and the corresponding synthetic lauroyltetrapeptide were as active in this respect as the muramyl-dipeptide, thus far considered as the minimal adjuvant-active structure of bacterial cell walls: the presence of a sugar moiety is therefore not a prerequisite for immunopotentiating activities.

Adjuvants, Immunologic↗